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Imedanzmessungen im Ösophagus – Klinische
Anwendungen
Zusammenfassung. Grundlagen: Impedanzmessungen
im O¨sophagus werden zunehmend ha¨ufiger zur Erken-
nung und Quantifizierung der Pra¨senz von Flu¨ssigkeiten
in der Speisero¨hren eingesetzt.
Methodik: U¨bersicht der klinischen Anwendungen
von Impedanzmessungen, insbesondere kombinierte
Impedanz-Manometrie und Impedanz-pH-Metrie.
Ergebnisse: Kombinierte Impedanz-Manometrie er-
mo¨glicht die Quantifizierung des Bolustransites und kla¨rt,
inwiefern o¨sophageale Motilita¨tsabnormalita¨ten von ei-
ner Bolustransitsto¨rung begleitet sind. Dies ist von beson-
derem Interesse fu¨r Patienten mit nicht-obstruktiver (i.e.
funktioneller) Dysphagie und Patienten mit post-operati-
ver Dysphagie.
Kombinierte Impedanz-pH-Metrie identifiziert
Refluxepisoden unabha¨ngig vom Sa¨uregehalt (i.e. pH).
Dieses ist wichtig fu¨r Patienten mit persistierenden
Beschwerden trotz sa¨urehemmender Therapie. Die
Mo¨glichkeit Refluxepisoden mit pH>4 zu identifizie-
ren, bringt neue Fragen betreffend der optimalen Thera-
pie fu¨r Patienten mit symptomatischem nicht-saurem
Reflux.
Schlussfolgerungen: Impedanzmessungen ermo¨g-
lichen uns Flu¨ssigkeitsbewegungen in der Speisero¨hre
zu identifizieren. Die klinische Wertigkeit dieser zusa¨tz-
lichen Information du¨rfte durch zuku¨nftige Studien
gekla¨rt werden.
Schlu¨sselwo¨rter: O¨sophagusmanometrie, o¨sophageale
pH-Metrie, Impedanzmessungen, kombinierte Impe-
danz-Manometrie, kombinierte Impedanz-pH-Metrie.
Summary. Background: Esophageal impedance mea-
surements are increasingly used to identify and quantify
the presence of fluids in the esophagus.
Method: A review of the available literature on
clinical applications of impedance including combined
impedance-manometry testing and combined imped-
ance-pH monitoring is done.
Results: Combined impedance-manometry testing
offers the opportunity to quantify esophageal bolus tran-
sit and clarifies the implications of esophageal motility
abnormalities on esophageal function. This is of particu-
lar interest in patients with non-obstructive dysphagia
and in patients with post-fundoplication dysphagia.
Combined impedance-pH monitoring allows the
detection of gastroesophageal reflux episodes inde-
pendent of pH. This is of particular importance when
evaluating patients with persistent symptoms on acid
suppressive therapy. The ability to detect gastroesophage-
al reflux episodes with pH>4 unfolds new questions on
the optimal approach to patients with symptomatic non-
acid reflux.
Conclusions: Impedance technology allows the
detection of fluid movements in the esophagus; further
studies will determine the clinical utility of this new
information.
Keywords: Esophageal manometry, esophageal pH
monitoring, multichannel intraluminal impedance
(MII), combined impedance manometry, combined im-
pedance-pH monitoring.
Introduction
In 1991, Silny described a novel modality for evaluating
bolus movement in hollow gastrointestinal viscera by
means of electrical impedance measurements [1]. In the
years that followed, multichannel intraluminal imped-
ance (MII) has been developed from a research to a clini-
cal tool. Currently, it is used to clarify esophageal bolus
transit in various esophageal motility abnormalities and
thus it changed the paradigm of gastroesophageal reflux
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testing. The addition of impedance to conventional esoph-
agealmanometry (combined impedance-manometry test-
ing) allows assessing bolus presence and transit without
the use of radiating energy. The addition of impedance to
pH monitoring (combined impedance-pH monitoring)
allows detecting gastroesophageal reflux episodes inde-
pendent of their acid content and allows distinguishing
between liquid, gas and mixed reflux episodes.
Methods
This contribution highlights basic concepts of impedance
testing and clinical applications of combined impedance-
manometry testing and impedance-pH monitoring. Sta-
tistics were not applied.
Results
Basic concepts and validation of bolus transit
measurements assessed by multichannel impedance
The basic component of MII testing is the impedance
circuit. Alternating current is applied to two steel rings
mounted on a catheter creating an impedance-measuring
segment. Because the catheter is not conducting electrical
current, the presence of electrical charges around the
catheter is required to close the electrical circuit. When
placed inside the esophagus, ions in the esophageal mu-
cosa will close the electrical circuit and the system will
measure a relative stable impedance baseline of 1500–
3000Ohm. The presence of liquids within the impedance-
measuring segment (i.e. between the two steel rings)
improves electrical conductivity and the system will mea-
sure low impedance values. The appearance of a liquid
bolus in the impedance-measuring segment induces a
rapid decline in impedance, which will remain low as
long as the bolus bridges both rings. Once the esophageal
peristalsis clears the bolus out of the impedance-mea-
suring segment, impedance values raise and return to
baseline. Conversely, the presence of air in the imped-
ance- measuring segment decreases electrical conductiv-
ity and the system will measure high impedance values.
The appearance of gas in the impedance-measuring seg-
ment will produce a rapid rise in intraluminal impedance,
which will then return to baseline once the air bolus
passes out of the impedance-measuring segment. These
declines and raises in intraluminal impedance are used to
determine the presence of liquid, gas and mixtures of
liquids and gas within the esophagus. By convention liq-
uid bolus entry point is declared when impedance
decreases by 50% from baseline to nadir and bolus exit
when impedance rises back to this 50% value. The entry
point of gas is declared when there is a sudden rise in
impedance of more than 3000 Ohms above baseline. In
the case of mixed (i.e. liquid-gas or gas-liquid) boli, bolus
entry and exit points are declared when impedance drops
recovers to the 50% value between baseline and nadir.
Mounting multiple impedance-measuring segments
on the same catheter allows not only detecting bolus
presence at various levels inside the esophagus but also
determining the direction of bolus movement within the
esophagus. Changes in impedance occurring in time from
proximal to distal indicate an antegrade bolus movement
as seen during swallowing while impedance changes oc-
curring in time from distal to proximal indicate a retro-
grade bolus movement as seen during reflux (Fig. 1). The
ability to distinguish between liquid and gas allows mul-
Fig. 1: Swallow and reﬂux episode identiﬁed by multichannel intraluminal impedance. Multiple impedance segments mounted on the same
catheter (left) identify antegrade bolus movements (i.e. swallows) as changes in intraluminal impedance baseline advancing over time from the
proximal to distal channel and retrograde bolus movements (i.e. reﬂux episodes) as changes in intraluminal impedance advancing over time from
distal to proximal. In this example, the reﬂux episode reaches a height of 9 cm above the LES
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tichannel intraluminal impedance to characterize the
physical properties of the refluxate and classify reflux epi-
sodes as liquid, gas or mixed (Fig. 2).
The ability of multichannel intraluminal impedance
to detect bolus movement has been validated by Silny
et al. [2] and Simren et al. [3] based on synchronized
videofluoroscopy and impedance recordings. Considering
bolus entry at a 50% drop in impedance from baseline to
nadir and bolus exit at the recovery of impedance to the
50% value, Simren et al. [3] found a strong correlation
between both methods for the measurement of the time
to esophageal filling (r¼ 0.94; p<0.0001) and time to
esophageal emptying (r¼ 0.89; p<0.0001). Evaluating
the correlation between impedance and barium swallows
in 13 healthy volunteers, Iman et al. found an agreement
between barium and impedance bolus transit or stasis in
97% (72=74) of swallows [4].
In summary, impedance measurements can de-
tect liquid, gas and mixed bolus presence in the esoph-
agus and quantify liquid bolus presence as the time
elapsed between the 50% drop in impedance from
baseline to nadir to the recovery of impedance to the
50% value. Using multiple impedance measuring seg-
ments (MII), one can determine bolus presence at mul-
tiple levels in the esophagus and distinguish swallowing
from reflux episodes.
Esophageal function testing using combined
impedance-manometry
Esophageal manometry is the gold standard in evaluating
esophageal dysmotilities. In the past years, increasing
computing power and miniature sensors allowed the de-
velopment of high-resolution manometry and topograph-
ic plotting of the signal [5]. While providing information
on amplitude, duration and peristaltic sequence of esoph-
ageal contraction, manometry provides only indirect in-
formation on esophageal bolus transit, the actual function
of the esophagus. Until recently, esophageal function was
determined mainly with barium videofluoroscopy. Com-
bining manometry with videofluoroscopy improved our
understanding of esophageal peristalsis but is not suitable
for routine clinical use because of the use of radiation
(limiting the number of swallows to be evaluated) and
the need to coordinate and schedule both procedures
(manometry and barium videofluoroscopy) in the same
time-slot.
The addition of impedance channels to a manome-
try channel does not change the external dimension of the
catheter and, from a patient’s perspective combined im-
pedance manometry is no different than conventional
manometry. Indications for combined impedance-ma-
nometry are the same for conventional manometry [6].
Owing to the good correlation and agreement of imped-
ance and fluoroscopy (see above) combined impedance
manometry offers the opportunity to evaluate both pres-
sure changes and bolus transit during the same swallows
and, since there is no radiating energy allows investigating
an unlimited number of swallows.
Studies in normal volunteers by Srinivasan et al.
confirmed the ability of MII to characterize bolus transit
through the esophagus of liquid, semisolids and solid
boluses [7]. Noticing the same changes in intraluminal
impedance during swallowing of liquid boluses from
1cc to 10 cc confirmed the high degree of sensitivity in
identifying bolus presence but limited ability of imped-
ance to estimate volumes of intraesophageal boluses.
In an initial step of introducing impedance-ma-
nometry into clinical practice was establishing normal
values. In a multicenter study, we established normal val-
ues for this technique based on data from 43 healthy US
Fig. 2: Examples of liquid, mixed and gas reﬂux episodes identiﬁed during combined impedance pH monitoring. Liquid-only reﬂux episodes are
identiﬁed as rapid decline in impedance advancing from distal to proximal. Gas-only reﬂux episodes are identiﬁed as rapid increases in impedance
advancing from distal to proximal channel. Mixed (gas-liquid) reﬂux episodes include features of both gas (rise in impedance) and liquid (decline in
impedance) changes in impedance
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volunteers [8]. Analyzing esophageal bolus transit of 10
saline and 10 viscous swallows, we found that more than
90% of healthy volunteers cleared at least 80% of liquid
swallows and at least 70% of viscous swallows. Examples
of swallows with complete and incomplete bolus transit
are shown in Fig. 3. These values were later confirmed by
a Dutch-Australian multicenter study in 42 healthy volun-
teers using combined water-perfused manometry-imped-
ance systems [9]. A third set of normal data for combined
impedance-manometry testing was reported by Nguyen
et al. in a group of 25 healthy subjects [10]. Bolus transit
parameters were similar to prior studies albeit using yo-
ghurt as semisolid test substance. Of particular interest in
Nguyen’s study are normal values of the esophageal im-
pedance baseline and deglutitive impedance gradient
during saline and yoghurt swallows.
The next step in evaluating the use of combined
impedance-manometry in clinical practice was evaluating
if evaluating bolus transit translates in additional infor-
mation compared to conventional manometry. Using
combined impedance-manometry in 350 consecutive
patients with various manometric abnormalities, we char-
acterized bolus transit abnormalities in these groups of
patients [11]. We found abnormal bolus transit for liquid
(i.e. incomplete bolus transit for at least 30% of liquid
swallows) and viscous (i.e. incomplete bolus transit for
at least 40% of liquid swallows) in all patients with acha-
lasia and scleroderma proving the ability of impedance
measurements to detect predictable severe transit abnor-
malities. Conversely, normal bolus transit for liquid was
identified in at least 95% of patients with normal manom-
etry, nutcraker esophagus and isolated LES abnormalities
(i.e. poorly relaxing LES, hypertensive and hypotensive
LES). Approximately half of patients with ineffective
esophageal motility (IEM) and distal esophageal spasm
(DES) had normal bolus transit for liquid.
Following up on the bolus transit abnormalities
identified in patients with IEM, we evaluated manomet-
ric predictors for normal bolus transit in these patients
[12]. Data from 70 IEM patients indicated that there is
no perfect (i.e. highly sensitive and highly specific)
manometric cutoff to predict complete bolus transit
and that the current manometric criteria for diagnosing
IEM (i.e. 30% or more manometric ineffective swallows)
is so sensitive and lacks the specificity for identifying
contractions accompanied by abnormal bolus transit.
In addition, when analyzing bolus transit for liquid and
viscous swallows, we found that approximately one
third of patients with IEM had normal bolus transit
for liquid and viscous (i.e. mild functional defect), ap-
proximately one third had abnormal bolus transit for
either liquid or viscous (i.e. moderate functional defect)
and another third abnormal bolus transit for both liq-
uid and viscous (i.e. severe functional defect). The clin-
ical utility of stratifying IEM in groups of patients mild,
moderate and severe function abnormalities depends
on the outcome of studies evaluating the potential this
grading scheme to identify patients at risk for develop-
ing post-operative dysphagia.
Conchillo et al. reported on the role of combined
impedance-manometry in patients with non-obstructive
dysphagia [13]. Evaluating 40 patients with dysphagia in
the absence of structural lesions (20 patients with normal
motility, 13 IEM, 4 DES and 3 achalasia), the authors
found abnormal transit for liquid and=or viscous boluses
in 35.3% of patients with normal motility, 66.7% of DES
patients and in 100% of patients with achalasia. These
findings indicate that the addition of impedance to ma-
Fig. 3: Combined impedance-manometry tracings depict examples of manometric ineffective contractions with complete and incomplete bolus
transit. Combined impedance-manometry catheter has circumferential pressure transducer in the LES, and matching impedance-manometry
channels at 5, 10, 15 and 20 cm above the LES. Both contractions are manometric ineffective as the pressure in at least one distal channel is
below 30mmHg. The ﬁrst swallow has complete bolus transit deﬁned as bolus entry in the proximal and bolus exit in all three distal channels. The
second swallow has incomplete bolus transit deﬁned as missing bolus exit in at least one distal channel
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nometry identifies esophageal function abnormalities in
patients with non-obstructive dysphagia in which ma-
nometry would have been normal or unspecific.
Combined impedance-manometry has been recent-
ly employed to evaluate changes in esophageal function
in untreated (38) and treated patients with achalasia (10
Botox or pneumatic dilatation and 16 Heller myotomy)
[14]. Although esophageal function was not normalized
by currently used criteria (i.e. 80% liquid swallows with
complete bolus transit and 70% viscous swallows with
complete bolus transit), Tatum et al. found a statistical
significant (p<0.05) difference in percentage of swallows
with complete bolus transit between untreated patients
(liquid 5%, viscous 2% swallows with complete bolus
transit) and patients after Heller myotomy (liquid 28%,
viscous 19% swallows with complete bolus transit).
Yigit et al. evaluated the role of impedance-ma-
nometry in evaluating patients with post-fundoplication
dysphagia [15]. The analysis of impedance-manometry
tracings in 80 patients undergoing Nissen fundoplication
(52 with and 28 without dysphagia) revealed similar (p¼
ns) proportions of patients with abnormal esophageal
peristalsis in the group complaining of dysphagia (17%)
and those without dysphagia (14%) but an increased
(p<0.01) proportion of patients with abnormal bolus tran-
sit in the dysphagia (61%) vs. the non-dysphagia (32%)
group. These findings suggest that evaluating esophageal
bolus transit may be more important than esophageal
peristalsis in post-fundoplication dysphagia.
In summary, present data indicate that combined
impedance-manometry provides more information com-
pared to conventional manometry. Information on bolus
transit is important in explaining dysphagia in patients in
whom conventional manometry would have indicated
normal or minor abnormalities and in patients with
post-fundoplication dysphagia. Further outcome studies
are warranted to explore the ability of impedance-ma-
nometry to predict the development of post-fundoplica-
tion dysphagia.
Reﬂux monitoring using combined
impedance-pH monitoring
Combined impedance-pH monitoring represents an im-
portant shift in the paradigm of reflux testing. Until re-
cently, gastroesophageal reflux monitoring was similar to
esophageal pH monitoring. Esophageal pH monitoring
exploited the fact that gastric secretions have a high acid
concentration (i.e. low pH values) and gastroesophageal
content refluxing into the esophagus produces rapid
declines in esophageal pH. The ability of impedance mea-
surement to detect bolus presence in the esophagus as
changes in electrical conductivity within the esophagus
allows monitoring gastroesophageal reflux episodes inde-
pendent of their acid content. This is of particular impor-
tance given the use of proton pump inhibitors (PPI) in
patients with or suspected to have gastroesophageal re-
flux. Because PPI trials are recommended as diagnostic
tests for GERD in patients with symptoms suspected to
be caused by reflux disease and the very convenient
effect=side-effect profile of PPIs, many patients referred
to gastrointestinal specialists with reflux symptoms are
on or already tried PPI therapies. Consequently, there
has been a shift in patients referred for testing from
patients referred to diagnose GERD to patients with per-
sistent symptom on acid suppressive therapy. In this
situation, the ability to monitor gastroesophageal reflux
episodes in patients on acid suppressive therapy is of
pivotal importance.
Combined impedance-pH monitoring identifies
gastroesophageal reflux episodes by changes in intralumi-
nal resistance to alternating current (i.e. impedance) and
data from the pH sensor are used to characterize the acid
content of reflux episodes. Given previous experiences
with pH monitoring gastroesophageal reflux episodes ac-
companied by a decline in reflux below pH 4 are consid-
ered acid whereas reflux episodes with a pH above 4 are
considered non-acid. In a recent consensus conference,
11 esophageal experts proposed a new set of definitions
for reflux episodes identified by combined impedance-pH
monitoring [16]. The revised classification maintains the
same criteria for acid reflux (drop in pH from above to
below 4) and coins reflux episodes occurring while esoph-
agel pH is below 4 as ‘‘superimposed reflux’’. Acknowl-
edging that solutions with a pH between 4 and 7 are
acidic by chemical criteria the group proposed the term
‘‘weakly acidic’’ to MII-detected reflux episodes during
which the pH is between 4 and 7 and the term ‘‘weakly
alkaline’’ reflux to episodes during which the pH does not
drop below 7 (Table 1).
The importance of combined impedance-pH moni-
toring has been highlighted by studies comparing gastro-
esophageal reflux off and on acid suppressive therapy.
Tab. 1: Traditional and revised classification of gastroesophageal reflux episodes
pH pH monitoring Impedance-pH monitoring
Traditional classiﬁcation Revised classiﬁcation (Oporto Group 2002 [14])
Less than 4 Acid reﬂux Acid reﬂux (MII detected
reﬂux with pH  4)
Acid reﬂux (MII detected reﬂux with drop in pH from
above to below 4) Superimposed reﬂux (MII detected
reﬂux starting while pH less than 4)
Between 4 and 7 No reﬂux Non-acid (MII detected
reﬂux with pH>4)
Weakly acidic reﬂux
Greater than 7 Weakly alkaline reﬂux
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Evaluating 12 patients with heartburn off medication and
then after 7 days of omeprazole 20mg twice daily, Vela et
al. found that in the post-prandial period acid suppressive
therapy reduced the number of gastroesophageal reflux
episodes with pH<4 (i.e. acid reflux episodes) and led to
an apparently paradoxical increase in gastroesophageal
reflux episodes with pH>4 (i.e. non-acid reflux episodes)
the overall number of all reflux episodes (i.e. acid and
non-acid reflux episodes) remained the same. These data
underscored the concept that PPIs change only the acid
content composition of gastroesophageal reflux in the
post-prandial period.
Normal values for combined impedance-pH moni-
toring have been established in a multicenter study in 60
healthy volunteers [17]. Data in normal volunteers advo-
cate that in the absence of acid suppressive therapy the
vast majority of GER episodes are acidic, with non-acid
GER episodes limited primarily to post-prandial periods.
The chief interest in this study is the observation that the
time intraesophageal pH is below 4 (detected by pH) is
much longer compared to the actual acid bolus presence
time (detected by impedance) underscoring the observa-
tion that acid clearance requires not only the removal of
the bolus but also the neutralization of the mucosal acid.
These data confirm prior scintigraphic-pH data by Helm
et al. that demonstrated that esophageal acid clearance
time (assessed by pH) was much longer compared to the
time the radiolabeled HCl bolus was present in the esoph-
agus [18]. In addition to the US-Belgian normal values,
currently two more sets of normal values from French-
Belgian [19] and Italian [20] cohorts of healthy volunteers
not taking any acid suppressive therapy are available.
While normal values proposed by the US-Belgian and
French-Belgian cohort are similar, Italian normal values
are somewhat lower (Table 2). This is most probably
explained by Zentilin et al. who conducted the diet study;
controlled food intake (Mediterranean diet)that produced
less reflux episodes was compared to ‘‘ad libitum’’ diets
used in the other studies.
Given the ability of combined impedance-pH mon-
itoring to identify reflux episodes independent of pH, this
tool offers much scope to evaluate the relationship be-
tween persistent symptoms on acid suppressive therapy
and reflux episodes. Studies evaluating the relationship
between persistent symptoms on twice daily PPI therapy
and reflux episodes by Mainie et al. [21] and Zerbib et al.
[22] documented that in 40–50% of patients reporting
esophageal symptoms during the monitoring had symp-
toms associated with gastroesophageal reflux. Because
potent acid suppressive therapy (PPI bid) reduced gastric
acid concentration, in most patients the association was
positive for non-acid reflux. In a recent study, evaluating
patients with persistent symptoms on PPI once daily,
Becker et al. [23] reported abnormal impedance-pH find-
ings (abnormal distal esophageal acid exposure or abnor-
mal number of MII-detected reflux episodes) in 39% of
patients. Following up patients after escalated therapy for
at least 3 months, the authors recorded a better (p<0.01)
symptomatic relief in patients with abnormal impedance-
pH results (90%) compared to patients with normal im-
pedance-pH findings (43%). These findings promulgate
that combined impedance-pH monitoring facilitates a
more focused therapeutic approach to patients with PPI-
resistant GERD.
Another area of interest for combined impedance-
pH monitoring is patients with atypical GERD symptoms.
Using combined impedance-pH monitoring Sifrim et al.
evaluated 22 patients with persistent cough attributed
to gastroesophageal reflux and spotted-10 patients (45%)
with a positive temporal association (i.e. positive symptom
association probability; SAP) between cough and reflux
[24]. These patients were investigated after abandoning
acid suppressive therapy and half of them had a positive
SAP for cough and acid reflux, 20% for cough and either
acid reflux or weakly acidic reflux and 30% of patients for
cough and weakly acidic reflux only.
Evaluating 50 patients with persistent cough on acid
suppressive therapy, we found a positive symptom asso-
ciation between cough and non-acid reflux in 13 (26%)
patients on PPI bidH2RA qhs [25]. Six patients with
positive symptom index on impedance-pH monitoring
underwent laparoscopic fundoplication and became as-
ymptomatic off acid-suppressive therapy during follow-
up evaluations (median time, 17 months; range, 12–27
months).
These studies imply that gastroesophageal reflux
with a pH above 4 can play a vital role in the patho-
genesis of chronic cough both in patients on or off acid
suppressive therapy. These patients should be tested as
finding a positive symptom association can have clini-
cal implications.
The impact of impedance-pH monitoring on clini-
cal management is currently scrutinized. Preliminary data
suggest that patients with symptomatic non-acid reflux
on acid suppressive therapy benefit from reflux-reducing
interventions. In an observational study, Mainie et al. re-
ported on the efficacy of laparoscopic fundoplication in
patients with symptomatic reflux on PPI bid identified by
impedance-pH monitoring [26]. Nineteen patients who
underwent combined impedance-pH monitoring prior
Tab. 2: These are the normal values for
combined impedance-pH monitoring based
on 95th percentile data in healthy volunteers
not taking acid suppressive therapy
US-Belgian
[17]
(N¼ 60)
French-
Belgian [18]
(N¼ 72)
Italian
[20]
(N¼ 25)
Esophageal pH data
%time pH<4 total 6.7% 5.0% 4.0%
upright 9.7% 6.2% 5.0%
recumbent 2.1% 5.3% 3.0%
Esophageal MII data
Nr. reﬂux episodes total 73 75 61
acid 55 50 51
weakly acid 26 33 38
weakly alkaline 1 15 18
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to laparoscopic fundoplication were followed up after a
median 14 months (range 7–25) and asked if they still had
symptoms or were taking PPIs. Out of the 18=19 patients
with a positive symptom association during combined
impedance-pH monitoring, 16=17 were asymptomatic or
markedly improved (one patient was not followed up)
and persistent symptoms occurred in one patient with
negative symptom index on the pre-operative examina-
tion and another patient with positive symptom index for
ENT symptoms and non-acid reflux. Albeit being an un-
controlled and not randomized study, this observation
suggests that patients with documented positive symp-
tom association with ongoing gastroesophageal reflux
on acid suppressive therapy can be treated by laparoscop-
ic fundoplication [27].
Rumination and aerophagia are two functional
esophageal disorders in which impedance measure-
ments can help establishing the correct diagnosis and
direct management. According to the Rome II criteria,
rumination is defined as a chronic or recurrent regur-
gitation of recently ingested food into the mouth with
subsequent remastication and swallowing continue
for at least 3 months in the absence of nausea and
vomiting [28]. These patients are not aware of the in-
voluntary increase in abdominal pressure leading to
regurgitation of recently ingested food back into the
esophagus and mouth. A hasty history may confound
rumination with regurgitation attributed to GERD. Unlike
GERD, rumination episodes are repeated many times
during or immediately after a meal and stop once gastric
content becomes acidic. Since most reflux episodes are
non-acidic, attempts to identify rumination by conven-
tional pH monitoring have been difficult. Combined im-
pedance-manometry with pressure transducers placed
into the stomach documented the sequence of rise in
intraabdominal pressure successfully before each rumi-
nation episode and hereby objectively diagnose rumina-
tion [29].
Aerophagia is characterized by sucking air into the
esophagus and belching it out before it reaches the stom-
ach. Most patients complaining of belching are often eval-
uated for reflux disease or dyspepsia. Owing to the high
sampling frequency (50Hz), esophageal multichannel
intraluminal impedance monitoring can identify the
correct sequence of air being swallowed=sucked into the
esophagus and then expelled rapidly (i.e. supragastric
belching) [30]. Diagnosing these patients in a better fash-
ion is important since patients with supragastric belching
are likely to benefit from behavioral therapy and not from
antireflux surgery.
In summary, combined impedance-pH monitoring
identifies gastroesophageal reflux episodes independent
of their acid concentration. This makes impedance-
pH monitoring the method of choice when evaluating
patients with atypical reflux symptoms or patients with
persistent symptoms on acid suppressive therapy.
Preliminary data signal that patients with documented
positive symptom association benefit from antireflux sur-
gery. Impedance monitoring also offers the opportunity
to identify and correctly diagnose functional esophageal
disorders such as rumination and aerophagia.
Conclusions
Impedance technology offers clinicians and investigators
to evaluate the movement of fluids (liquids and gas) in the
esophagus. Combined with manometry, it helps to clarify
the implications of abnormal peristalsis on esophageal
bolus transit. Combined with pH, it helps to clarify the
mechanisms of persistent symptoms on acid suppressive
therapy, identify the relationship between reflux and extra-
esophageal symptoms and offer the ability to document
functional esophageal disorders objectively such as aero-
phagia and rumination. At the moment, outcome studies
are warranted to enhance our understanding of the role
of impedance testing in predicting the development of
post-fundoplication dysphagia and in managing patients
with symptomatic reflux on acid suppressive therapy.
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